Breaking News, Promotions & Moves

Inotek Appoints CEO

Southwell to lead efforts to advance trabodenoson

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

David. P. Southwell has been named president and chief executive officer of Inotek Pharmaceuticals, Inc., and will also join the board of directors. Mr. Southwell has more than 20 years of experience in pharma and biopharma including financings, mergers and acquisitions, and general corporate leadership.   Prior to joining the company, he served as executive vice president and chief financial officer of Human Genome Sciences (acquired by GlaxoSmithKline in 2012). Before joining the management te...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters